Literature DB >> 1822510

Hepatitis E virus. Comparison of 'New and Old World' isolates.

G R Reyes1, C C Huang, P O Yarbough, A W Tam.   

Abstract

The etiologic agent responsible for epidemics of enterically-transmitted non-A, non-B hepatitis has been molecularly characterized as the hepatitis E virus (HEV). The cloning of a portion of the Burma strain of HEV (HEV(B); 'Old World' strain) has been described together with the isolation of a contiguous overlapping set of cDNA clones representing the entire viral genome. Our studies have led to a model for the genomic organization of this positive strand, polyadenylated, RNA virus. Molecular clones encompassing the entire genome were also isolated from a cDNA library made from the Mexico strain of HEV (HEV(M); 'New World' strain). The translated nucleotide sequence of the Mexico isolate confirmed the genomic organization as first interpreted for HEV(B). This refers to the utilization of at least three different discontinuous open reading frames for protein expression and their apparent organization into 5' nonstructural and 3' structural gene regions. The comparison of the two strains identified a localized area of divergent nucleic and amino acid sequence that was previously reported in the region encoding the nonstructural gene(s) (ORF1). The HEV expression strategy involves at least two subgenomic poly-A transcripts that are co-terminal with the 3' end of the virus. Cross-reactive (type-common) epitopes are shared between the two divergent strains. It will be important to determine in future studies if any correlation exist between the viral pathobiology in animals or humans and the primary sequence of the virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822510     DOI: 10.1016/0168-8278(91)90050-l

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  A new Chinese isolate of hepatitis E virus: comparison with strains recovered from different geographical regions.

Authors:  S Yin; R H Purcell; S U Emerson
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

2.  Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo.

Authors:  R S Pudupakam; Y W Huang; T Opriessnig; P G Halbur; F W Pierson; X J Meng
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

3.  Serological evidence of hepatitis E virus infection in an indigenous North American population.

Authors:  G Y Minuk; A Sun; D F Sun; J Uhanova; L E Nicolle; B Larke; A Giulivi
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

4.  Expression of hepatitis E virus putative structural proteins in recombinant vaccinia viruses.

Authors:  M Carl; S N Isaacs; M Kaur; J He; A W Tam; P O Yarbough; G R Reyes
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

Review 5.  Zoonotic Hepatitis E Virus: An Ignored Risk for Public Health.

Authors:  Yuchen Nan; Chunyan Wu; Qin Zhao; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-12-04       Impact factor: 5.640

Review 6.  Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges.

Authors:  Yuchen Nan; Chunyan Wu; Qin Zhao; Yani Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2018-02-19       Impact factor: 5.640

Review 7.  Viral Hepatitis Other than A, B, and C: Evaluation and Management.

Authors:  Amanda Cheung; Paul Kwo
Journal:  Clin Liver Dis       Date:  2020-04-13       Impact factor: 6.126

8.  Use of immuno-dominant epitope derived from genotype 4 as a diagnostic reagent for detecting the antibodies against Hepatitis E Virus.

Authors:  Bing-shui Xiu; Xiao-yan Feng; Jing He; Kun Chen; Jing Liu; Zhen-hua Dai; Xi-qin Yang; Guo-hua Wang; You-chun Wang; He-qiu Zhang; Xiao-guo Song; Cui-xia Zhu
Journal:  Virol J       Date:  2013-04-25       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.